- Home
- RLMD vs CATO Comparison
RLMD vs CATO Comparison
Compare RLMD & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- CATO
- Stock Information
- Founded
- RLMD 2004
- CATO 1946
- Country
- RLMD United States
- CATO United States
- Employees
- RLMD N/A
- CATO N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- CATO Clothing/Shoe/Accessory Stores
- Sector
- RLMD Health Care
- CATO Consumer Discretionary
- Exchange
- RLMD Nasdaq
- CATO Nasdaq
- Market Cap
- RLMD 53.4M
- CATO 57.6M
- IPO Year
- RLMD N/A
- CATO N/A
- Fundamental
- Price
- RLMD $1.59
- CATO $4.64
- Analyst Decision
- RLMD Buy
- CATO
- Analyst Count
- RLMD 3
- CATO 0
- Target Price
- RLMD $5.00
- CATO N/A
- AVG Volume (30 Days)
- RLMD 1.6M
- CATO 202.2K
- Earning Date
- RLMD 11-06-2025
- CATO 08-21-2025
- Dividend Yield
- RLMD N/A
- CATO 3.68%
- EPS Growth
- RLMD N/A
- CATO N/A
- EPS
- RLMD N/A
- CATO N/A
- Revenue
- RLMD N/A
- CATO $650,830,000.00
- Revenue This Year
- RLMD N/A
- CATO N/A
- Revenue Next Year
- RLMD N/A
- CATO N/A
- P/E Ratio
- RLMD N/A
- CATO N/A
- Revenue Growth
- RLMD N/A
- CATO N/A
- 52 Week Low
- RLMD $0.24
- CATO $2.19
- 52 Week High
- RLMD $3.98
- CATO $6.70
- Technical
- Relative Strength Index (RSI)
- RLMD 74.57
- CATO 69.83
- Support Level
- RLMD $1.44
- CATO $3.84
- Resistance Level
- RLMD $1.72
- CATO $4.92
- Average True Range (ATR)
- RLMD 0.24
- CATO 0.28
- MACD
- RLMD 0.05
- CATO 0.04
- Stochastic Oscillator
- RLMD 86.90
- CATO 78.46
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.